Outbreak of multiresistant OXA-24-and OXA-51-producing Acinetobacter baumannii in an internal medicine ward

Japanese Journal of Infectious Diseases

Volumn 66, Issue 4, 2013, Pages 323-326

  Tena, Daniel ^a   Martínez, Nora Mariela ^a   Oteo, Jesús ^b   Sáez, David ^b   Vindel, Ana ^b   Azañedo, María Luisa ^b   Sánchez, Lorenzo ^a   Espinosa, Alfredo ^a   Cobos, Juan ^a   Sánchez, Rosario ^a   Otero, Ignacio ^a   Bisquert, Julia ^a  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b CNM   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL ENZYME; CARBAPENEMASE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TIGECYCLINE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE CARRIER; DISEASE DURATION; ENVIRONMENTAL MONITORING; EPIDEMIC; GENE IDENTIFICATION; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HUMAN; INTERNAL MEDICINE; MALE; MENINGITIS; MORTALITY; MULTIDRUG RESISTANT ACINETOBACTER BAUMANNII; MULTILOCUS SEQUENCE TYPING; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY TRACT INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; WARD;

EID: 84880688561     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.66.323     Document Type: Article

References (23)

1. Karageorgopoulos, D.E. and Falagas, M.E. (2008): Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect. Dis., 8, 751-762.
2. Fournier, P.E. and Richet, H. (2006): The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin. Infect. Dis., 42, 692-699.
3. Playford, E.G., Craig, J.C. and Iredell, J.R. (2007): Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J. Hosp. Infect., 65, 204-211.
4. Falagas, M.E., Koletsi, P.K. and Bliziotis, I.A. (2006): The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J. Med. Microbiol., 55, 1619-1629.
5. Doi, Y., Husain, S., Potoski, B.A, et al. (2009): Extensively drugresistant Acinetobacter baumannii. Emerg. Infect. Dis., 15, 980-982.
6. Maragakis, L.L. and Perl, T.M. (2008): Acinetobacter baumannii: epidemiology, antimicrobial resistance and treatment options. Clin. Infect. Dis., 46, 1254-1263.
7. Clinical and Laboratory Standards Institute (2011): Performance standards for antimicrobial susceptibility testing, 20th informational supplement. M100-S21. vol. 31, no. 1. Clinical and Laboratory Standards Institute, Wayne, Pa.
8. Woodford, N., Ellington, M.J., Coelho, J.M., et al. (2006): Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents, 27, 351-353.
9. Turton, J.F., Ward, M.E., Woodford, N., et al. (2006): The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett., 258, 72-77.
10. Seifert, H., Dolzani, L. and Bressan, R., et al. (2005): Standardization and interlaboratory reproducibility assessment of pulsedfield gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol., 43, 4328-4335.
11. Tenover, F.C., Arbeit, R.D., Goering, R.V., et al. (1995): Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 33, 2233-2239.
12. Diancourt, L., Passet, V., Nemec, A., et al. (2010): The population structure of Acinetobacter baumannii: expanding multi-resistant clones from an ancestral susceptible genetic pool. PLoS One, 5, e10034.
13. Moet, G.J., Jones, R.N., Biedenbach, D.J., et al. (2007): Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn. Microbiol. Infect. Dis., 57, 7-13.
14. Munoz-Price, L.S. and Weinstein, R.A. (2008): Acinetobacter infection. N. Engl. J. Med., 358, 1271-1281.
15. Webster, C., Towner, K.J. and Humphreys, H. (2000): Survival of Acinetobacter on three clinically related inanimate surfaces. Infect. Control Hosp. Epidemiol., 54, 39-45.
16. Markogiannakis, A., Fildisis, G., Tsiplakou, S., et al. (2008): A Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains episodes of sepsis in a trauma intensive care unit. Infect. Control Hosp. Epidemiol., 29, 410-417.
17. Maragakis, L.L., Cosgrove, S.E., Song, X., et al. (2004): An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA, 292, 3006-3011.
18. Choi, W.S., Kim, S.H., Jeon, E.G., et al. (2010): Nosocomial outbreak of carbapenem-resistant Acinetobacter baumannii in intensive care units and successful outbreak control program. J. Korean Med. Sci., 25, 999-1004.
19. Sengstock, D.M., Thyagarajan, R., Apalara, J., et al. (2010): Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin. Infect. Dis., 50, 1611-1616.
20. Higgins, P.G., Dammhayn, C., Hackel, M., et al. (2010): Global spread of carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother., 65, 233-238.
21. Acosta, J., Merino, M., Viedma, E., et al. (2011): Multidrugresistant Acinetobacter baumannii harboring OXA-24 carbapenemase, Spain. Emerg. Infect. Dis., 17, 1064-1067.
22. Bou, G., Cervero, G., Dominguez, M., et al. (2000): Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of b-lactamases. J. Clin. Microbiol., 38, 3299-3305.
23. Grosso, F., Carvalho, K.R., Quinteira, S., et al. (2011): OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro? J. Antimicrob. Chemother., 66, 62-65.